The Madame will win this....

Quote

anonymous

Guest
This could be the best thing to happen to RVNC!! Someone who actually knows how to run a Filler/Toxin company...https://www.msn.com/en-us/money/top-stocks/revance-therapeutics-jumps-after-teoxane-offers-3-60-a-share/ar-AA1x34em
 






anonymous said:
This could be the best thing to happen to RVNC!! Someone who actually knows how to run a Filler/Toxin company...https://www.msn.com/en-us/money/top-stocks/revance-therapeutics-jumps-after-teoxane-offers-3-60-a-share/ar-AA1x34em
Click to expand...
What happens now? Assuming more delays and we have to do due diligence on the new offer? I can’t imagine shareholders would stick to the crown deal if they’re being offered 15% more
 












Absolutely based of her to come in dick swinging, two middle fingers to Mark and Crown after drawing out the original merger, bullying Mark into revealing how crap our finances were. Granted it’s her fault the Crown purchase price is as low as it is. I’m hoping it’s actually just a bluff to push Crown to push the price back up a bit.
 






anonymous said:
Absolutely based of her to come in dick swinging, two middle fingers to Mark and Crown after drawing out the original merger, bullying Mark into revealing how crap our finances were. Granted it’s her fault the Crown purchase price is as low as it is. I’m hoping it’s actually just a bluff to push Crown to push the price back up a bit.
Click to expand...
If you read the 14 D9 SEC filings the company has been for sale for over a year + with many looking at it. She simply was looking for the best price and position for her fillers, entry into the USA market. Revance tried selling off her contract, and accepting a low offer of $6.66 when she owned a majority of the shares. No good business person would go down without a fight when that first $6.66 offer was on the table - she knew first hand what the issues are at RVNC. It's an incredibly smart play.
 






anonymous said:
If you read the 14 D9 SEC filings the company has been for sale for over a year + with many looking at it. She simply was looking for the best price and position for her fillers, entry into the USA market. Revance tried selling off her contract, and accepting a low offer of $6.66 when she owned a majority of the shares. No good business person would go down without a fight when that first $6.66 offer was on the table - she knew first hand what the issues are at RVNC. It's an incredibly smart play.
Click to expand...
True - now madame will be respected. I guess she will ask mark who is crazy now?
 






The madame has been desperate to enter the US market for years. She has been equally desperate to get her hands on a toxin. This could be her once in a lifetime opportunity. I personally hope it does not go to Teoxane. The madame is a nightmare!!!
 












anonymous said:
If you think Revance’s leadership is bad you haven’t seen anything yet. Teoxane’s madame is a dictator. Just terrible.
Click to expand...
She might be but so what? Her company, which she started at age 22 and is global, successful and not going bankrupt in a fire sale right now. I think she will do just fine in the USA going up agaist the big 3. TEO is #2 in Europe for filler. She also garners much more respect with injectors than Crown does, which is what RVNC desparatly needs right now. The Teoxane Cosmetic RHA Skincare will partner nicely with RHA fillers, and Daxi in a portfolio. And if you think good 'ole Jeff Bedard at Crown isn't a dictator...ask your Crown rep. Pick your posion, I'd rather have the Madame who knows WTF she is doing with Fillers/Toxins/Injectables/Skincare than dealing with Crown.
 


















Funny I was thinking that was a great reason to STOP selling out to EU/Swiss companies.

Also, aren't we just talking about vanity skin products, or am I missing something? If so, honestly, I guess, who cares. But we still need to stop selling tech and IP to the Swiss, who still hide Nazi gold in their mountains, and who still operate the world's biggest crime syndicata aka Nestle.
 






anonymous said:
She might be but so what? Her company, which she started at age 22 and is global, successful and not going bankrupt in a fire sale right now. I think she will do just fine in the USA going up agaist the big 3. TEO is #2 in Europe for filler. She also garners much more respect with injectors than Crown does, which is what RVNC desparatly needs right now. The Teoxane Cosmetic RHA Skincare will partner nicely with RHA fillers, and Daxi in a portfolio. And if you think good 'ole Jeff Bedard at Crown isn't a dictator...ask your Crown rep. Pick your posion, I'd rather have the Madame who knows WTF she is doing with Fillers/Toxins/Injectables/Skincare than dealing with Crown.
Click to expand...
Credit to the women for building a successful company and turning it into a global player. She nevertheless remains a micromanager nightmare.
Teoxane is not #2 in Europe. The region is dominated by Allergan and Galderma. Possibly # 3 but most realistically # 4 behind Merz. How on earth can the Madame claim #2?
 






anonymous said:
Credit to the women for building a successful company and turning it into a global player. She nevertheless remains a micromanager nightmare.
Teoxane is not #2 in Europe. The region is dominated by Allergan and Galderma. Possibly # 3 but most realistically # 4 behind Merz. How on earth can the Madame claim #2?
Click to expand...
I think madame is doing better than we think. So our options are: crown, teoxane, bankruptcy or maybe prollenium. My hope right now is 1 teoxane, 2 crown, 3 bankruptcy. I would not put prollenium as 4 as it would be more nightmarish than the previous 3 options combined. Go madame!
 










































Top Bottom
Back
Quote